Final cohort of Phase 1 study projected to be complete in H1 2023 –
– Phase 2-enabling GLP toxicology studies projected to be complete in H2 2023 –
– Clinical update on all pipeline programs to be presented at the 2023 J.P. Morgan Healthcare Conference on January 12 at 10:30 a.m. PT –
https://finance.yahoo.com/news/aligos-therapeutics-track-complete-phase-130000041.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.